Business
Easton Pharmaceuticals Begins Discussions to Acquire an Interest in an Operating Casino and Hotel Resort in Greece with Revenues in Excess of 60 Million Euro Per Year
Easton Pharmaceuticals Begins Discussions to Acquire an Interest in an Operating Casino and Hotel Resort in Greece with Revenues in Excess of 60 Million Euro Per Year.
About this update from Easton Pharmaceuticals Inc
[{"type":"text","content":"\nTORONTO, ON, Aug. 22, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Easton Pharmaceuticals Inc. (OTC: EAPH) Announces that it has begun discussions to acquire an interest or participate in the acquisition of an operating casino and hotel resort in Greece. The resort comprises of a private beach, 255 rooms and 20 suites, 8 restaurants, a wellness center, conference facilities and an 87 table/1,000 slot machine casino plus a VIP area.  \n As part of its plan to enter more lucrative market segments, Easton has begun discussions with a company acquiring an operating casino/hotel resort property in Greece. This is one of just 9 casinos operating in Greece. Easton’s CEO, Mr. Evan Karras, participated in the privatization of gaming in Greece in the 1990’s, has nurtured strong relationships and is familiar with the property and the gaming industry in the country. “This casino was one of the most successful casinos in Europe when it opened, and I am excited for the prospects of having Easton participate in such an incredible opportunity” stated Mr. Evan Karras. Mr. Karras further commented “This Agreement is one of several that Easton is looking to enter into for gaming globally and would bring the Company and its shareholders tremendous value and growth”. Easton is negotiating its participation with the company acquiring the property. The acquisition is at a substantial discount of its cost with Easton assembling a specialized gaming team to manage the property. The property offers substantial upside, both in the gaming sector, as well as the hospitality sector and along with redevelopment potential for luxury managed condominium vacation units.  The discussions are currently highly confidential and anticipated to be completed this month or shortly thereafter with additional detailed information to be provided in the coming days or as it becomes readily available and approved for release. About Easton Pharmaceuticals Easton Pharmaceuticals is a diversified specialty pharmaceutical company involved in various pharmaceutical sectors and other growing industries. The Company previously developed and owned an FDA-approved wound-healing medical drug and currently owns topically delivered drugs to treat cancer and other th...